Keywords
Abstract
Diffuse liver diseases, including fatty hepatosis, chronic hepatitis, including viral etiology, cirrhosis of the liver remain one of the central problems for public health throughout the world. In the world there are about 2,000 million people infected with the hepatitis B virus, of which more than 350 million are chronically infected and from 500,000 to 700,000 people. die annually from hepatitis B virus infection. About 130-170 million people. are chronically infected with the hepatitis C virus, and it is estimated that more than 350,000 people die each year from hepatitis C-related liver disease. As one of the strategic directions for the treatment of viral hepatitis, WHO considers it important to expand access to health care, systematic monitoring and combating drug resistance.